Signal Detection in EUROmediCAT: Identification and Evaluation of Medication-Congenital Anomaly Associations and Use of VigiBase as a Complementary Source of Reference.
Alana Y CavadinoLovisa SandbergInger ÖhmanTomas BergvallKristina StarHelen DolkMaria A LoaneMarie-Claude AddorIngeborg BarisicClara Cavero-CarbonellEster GarneMiriam GattBabak KhoshnoodKari KlungsoyrAnna Latos-BielenskaNathalie LelongReneé LutkeAnna Materna-KirylukVera NelenAmanda NevillMary O'MahonyOlatz MokoroaAnna PieriniHanitra RandrianaivoAnke RissmannDavid TuckerAwi WieselLyubov YevtushokJoan K MorrisPublished in: Drug safety (2021)
EUROmediCAT data should continue to be used for signal detection, accompanied by information from VigiBase and review of the existing literature to prioritise signals for further independent evaluation.